-
-
- Oct 25/26
CAR T cells shrink lymphoma everywhere, but survival depends on location - Oct 23/26
Canada’s HIV moonshot to ‘tickle’ the virus out of hiding - Oct 22/26
Review positions crosslinking as a multidimensional regulator of regenerative biomaterials - Oct 22/26
Clinical trial setup times fall sharply in U.K. - Oct 22/26
AI model decodes the language cells use to communicate - Oct 21/26
TCR-engineered T cells advance toward harder liver cancer targets - Oct 21/26
Stem-cell craniofacial therapy shows similar early patient-reported outcomes - Oct 21/26
Spanish survey finds high DMD gene-therapy willingness amid readiness gaps - Oct 20/26
Stem cell therapies improve tendon-bone healing in ACL animal models - Oct 20/26
Experts weigh risks of using gene therapies for common diseases - Oct 20/26
Global stem cell research community gathers in Kyoto, Japan to celebrate 20 years of iPSC discovery and innovation - Oct 19/26
From cells to organoids: Cytokines that shape 3D culture - Oct 19/26
Blood cell crashes after CAR-T therapy follow a predictable risk score, study finds - Oct 18/26
Weekly reads: G&D trio, Regenative Labs sues FDA, OCT4 sub, SpudCells, SRSF1 as an anti-aging factor? - Oct 18/26
Bacterial peptide-primed stem cell vesicles push colon cancer cells toward suicide - Oct 18/26
Single gene knockout strips lab-grown heart cells of immune visibility - Oct 18/26
CAR T-cell therapy may spare older patients’ memory more than younger ones - Oct 16/26
Engineered immune cells push cancer therapy into its next frontier - Oct 16/26
Scientists discover a molecular switch that drives T-cell exhaustion in cancer immunotherapy - Oct 15/26
FDA’s latest rare disease framework seeks to prioritize consistency in flexibility - Oct 15/26
Proof-of-concept for hydrocephalus gene therapy that could reduce reliance on shunts - Oct 15/26
Belgian startup revives Galapagos CAR-T research - Oct 15/26
Reprogramming gene expression networks could reverse biological aging - Oct 14/26
USC launches first-in-human trial of cartilage-protecting knee injection - Oct 14/26
Enhanced CAR T-cell therapy shows promise in trial for B-cell blood cancers - Oct 13/26
Lipid nanoparticles reprogram natural killer cells inside the body to fight cancer - Oct 13/26
DNA recording system reveals how a single cell becomes a body - Oct 12/26
Caribou halts allogeneic CAR T programs as funding pressures mount - Oct 12/26
FDA clears Phase 2 trial of B7-H3 CAR T MT027 for brain metastases - Oct 12/26
Immune signal IL-18 supercharges rare T cells for solid tumour therapy - Oct 12/26
The BioPharm Brief: Trials test CAR-T, immunology and targeted oncology - Oct 12/26
RNA edit swaps out OCT4 to make better stem cells - Oct 12/26
Donor-derived CD19 CAR-T cells deliver lasting remissions in leukemia patients after transplant failure - Oct 9/26
One researcher’s quest to cure neurodegenerative diseases gets personal - Oct 8/26
Canadian children’s hospitals expand AI-powered rare disease detection as gene therapy research advances - Oct 8/26
Reusing data could cut R&D costs and greatly increase gene editing’s reach: ARM - Oct 8/26
Activated protein C keeps blood stem cells resting and boosts transplant success - Oct 8/26
Inhaled stem cells for COPD: What would prove lasting benefit? - Oct 7/26
Metabolism holds the key to stronger CAR T cell therapies, review argues - Oct 7/26
Atsena’s Lighthouse gene therapy readout illuminates eye disease efficacy - Oct 6/26
Why the mouth matters: Dentists join the CAR-T therapy team - Oct 6/26
Platelet-powered cartilage cells move closer to the clinic with a new GMP blueprint - Oct 6/26
Viruses that board CAR cells: A modular push against solid tumours - Oct 5/26
AI learns to measure new bone growth in scaffolds, but standard metrics mislead - Oct 5/26
Stem cell feeder platforms boost natural killer cells for cancer immunotherapy - Oct 4/26
Gamma delta T cells blur the line between innate and adaptive immunity - Oct 4/26
Weekly reads: AI grant review, sham orgs trick academics, Origin Genomics, CRISPR babies - Oct 4/26
Engineered natural killer cells show potent activity against glioblastoma in new study - Oct 3/26
Stem cell rejuvenation pathway points to new periodontal bone repair strategy - Oct 2/26
Bioprinted human vascular organoid sheets restore blood flow in ischemic limbs - Oct 2/26
Engineered AAV capsid reaches the outer retina through a simple eye injection - Oct 1/26
Silencing NOTCH1 makes leukemia cells vulnerable to CD19 CAR-T attack - Oct 1/26
Taming the cytokine storm: How doctors are making CAR T-cell therapy safer - Oct 1/26
New mechanism of antiviral immunity discovered - Sep 30/26
Engineered T cells targeting Hepatitis B antigen show glimmer of benefit in advanced liver cancer - Sep 30/26
CAR-T therapy may cost less than stem cell transplants beyond the price tag, German data suggest - Sep 30/26
Masked AAV vectors switch on gene delivery only where disease signals strike - Sep 30/26
Engineered immune cells push melanoma therapy into a new era - Sep 30/26
Rice engineer brings ‘surgineering’ mindset to future of medicine - Sep 30/26
UB researchers grow salivary mini organs from pluripotent stem cells - Sep 28/26
Regenerative medicine needs more than stem cells - Sep 28/26
Study reveals why some patients reject off-the-shelf CAR T cells - Sep 28/26
Speaker: CAR T-cell trial deaths add ‘sobriety’ to discussions with autoimmune patients - Sep 28/26
AI identifies signs of aging in blood stem cells - Sep 28/26
China now leads the world in trials for next-gen CAR-T therapies - Sep 27/26
Some pancreatic cells are just one genetic tweak away from treating diabetes - Sep 27/26
Weekly reads: $100B NIH budget dream, Sholto David on YouTube, Jun Takahashi award, Muse cell developments - Sep 25/26
New study opens doors for precise control of cells using light - Sep 24/26
UCLA scientists receive CIRM grants to advance stem cell-based treatments for vision loss, infertility - Sep 24/26
Stanford researchers discover that the human brain may be two separate organs fused together - Sep 23/26
From CAR-T cells to cancer organoids: The technologies set to transform clinical oncology - Sep 23/26
Fatal inflammatory risks associated with CAR T-cell therapy - Sep 23/26
Reprogramming cells inside the body: The regenerative medicine frontier moving from lab to clinic - Sep 23/26
Stem cell therapy eases Crohn’s disease by blocking iron-driven cell death - Sep 22/26
Base editors correct Artemis mutations, offering new hope for SCID gene therapy - Sep 22/26
Bone marrow transplants offer surprising way to treat mitochondrial disease, Stanford Medicine study shows - Sep 22/26
CAR T-cell therapy enables safe pregnancies in autoimmune patients - Sep 22/26
University of Alberta launches regenerative medicine hub at Life Sciences Week - Sep 22/26
Tumour slice cultures reveal new pitfalls in testing AAV gene therapy for glioblastoma - Sep 22/26
How the body keeps insulin-producing cells in check may shape future diabetes therapies - Sep 22/26
Lexeo takes up the Mantle in $8M acquisition for Friedreich ataxia assets - Sep 21/26
Researchers restored a lost CAR T target in thyroid cancer - Sep 21/26
Beacon’s XLRP gene therapy set for filing after phase 3 win - Sep 21/26
Natural killer cells stay battle-ready in obesity-linked cancer terrain - Sep 21/26
Mikhail, Davis on board with regulatory framework tailored to rare disease therapies - Sep 21/26
New study identifies genes that help flatworms regenerate their brains - Sep 20/26
Weekly reads: Longeveron MSC trial disappoints, CRISPR ancestor VIPR, distinct human brain progenitors, FDA staffing woes - Sep 17/26
Why you should measure comparability debt before ever starting a study - Sep 16/26
Canada must reclaim its reputation as a leader in diabetes innovation
- Oct 25/26
-
